Two possibilities could explain this phenomenon: one is that the H2O2-REST signaling pathway might be downstream of T2DM-elevated blood glucose, and another is that local treatment with catalase or REST shRNA into the AVG could not affect blood glucose levels. This evidence concerns the gene REST and type 2 diabetes mellitus.